Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China · Delayed Price · Currency is CNY 8.90
-0.15 (-1.66%)
May 20, 2026, 2:15 PM CST
SHE:300016 Revenue
Beijing Beilu Pharmaceutical had revenue of 320.37M CNY in the quarter ending March 31, 2026, with 13.33% growth. This brings the company's revenue in the last twelve months to 1.24B, up 17.40% year-over-year. In the year 2025, Beijing Beilu Pharmaceutical had annual revenue of 1.21B with 22.54% growth.
Revenue (ttm)
1.24B
Revenue Growth
+17.40%
P/S Ratio
4.10
Revenue / Employee
1.05M
Employees
1,173
Market Cap
5.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.21B | 221.72M | 22.54% |
| Dec 31, 2024 | 983.55M | 92.84M | 10.42% |
| Dec 31, 2023 | 890.72M | 124.84M | 16.30% |
| Jan 1, 2023 | 765.88M | -94.02M | -10.93% |
| Jan 1, 2022 | 859.91M | 32.57M | 3.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.59B |
| Fuan Pharmaceutical (Group) | 1.74B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.68B |
| Tianjin Lisheng Pharmaceutical | 1.35B |
| Bide Pharmatech | 1.35B |
| Jiangsu Jibeier Pharmaceutical | 990.68M |
| Teyi Pharmaceutical Group Co.,Ltd | 839.27M |
| Zhongzhu Healthcare Holding Co.,Ltd | 544.73M |